Sphere Fluidics Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Sphere Fluidics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013452
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sphere Fluidics Ltd (Sphere Fluidics) is a life sciences company that offers analytical instrumentation and collaborative research services. The company offers products such as research instruments, consumables and industrial systems. Its research instruments include picodroplet single cell encapsulation system and picodroplet single cell assay and isolation system. Sphere Fluidics provides specialist chemicals for the microfluidic devices. Sphere Fluidics uses its Picodroplet technology to screen and identify unique candidates for therapeutic research. The company’s research and development finds applications in biopharmaceutical discovery, bioproduction, cell therapy, disease research, metagenomics and diagnostics. Sphere Fluidics is headquartered in Cambridge, the UK.

Sphere Fluidics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sphere Fluidics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sphere Fluidics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sphere Fluidics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sphere Fluidics Ltd, Medical Devices Deals, 2011 to YTD 2017 8
Sphere Fluidics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Sphere Fluidics Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Sphere Fluidics Raises USD2.7 Million in Financing Round 10
Sphere Fluidics Raises USD2.4 Million in Venture Financing 11
Sphere Fluidics Raises US$2.5 Million In Venture Financing 12
Partnerships 14
Plasticell Enters into Research Agreement with Sphere Fluidics 14
Dolomite Enters Into Distribution Agreement With Sphere Fluidics For Picodroplet Applications 15
Sphere Fluidics Enters Into Co-Development Agreement With Dolomite Centre 16
Licensing Agreements 17
Sphere Fluidics Secures License for Picodroplet Sorting 17
Sphere Fluidics Secures License for Surfactant Patent Family 18
Sphere Fluidics Enters Into Licensing Agreement with Cambridge University for Picodroplets 19
Sphere Fluidics Secures License for Picodroplet Technology 20
Sphere Fluidics Ltd – Key Competitors 21
Sphere Fluidics Ltd – Key Employees 22
Sphere Fluidics Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Government and Public Interest 24
Jul 17, 2017: Sphere Fluidics and Partners Win Major InnovateUK Grant to Develop the World’s First Desktop Genome Editing System 24
Other Significant Developments 25
Jan 24, 2017: Sphere Fluidics Launches E-commerce Site Allowing Researchers Rapid Access to Specialist Microfluidic Products 25
Feb 10, 2016: Sphere Fluidics Limited Wins $7 Million Investment for Development of Cyto-Mine – The Unique Single Cell Analysis System 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Sphere Fluidics Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Sphere Fluidics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Sphere Fluidics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sphere Fluidics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sphere Fluidics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sphere Fluidics Ltd, Medical Devices Deals, 2011 to YTD 2017 8
Sphere Fluidics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Sphere Fluidics Raises USD2.7 Million in Financing Round 10
Sphere Fluidics Raises USD2.4 Million in Venture Financing 11
Sphere Fluidics Raises US$2.5 Million In Venture Financing 12
Plasticell Enters into Research Agreement with Sphere Fluidics 14
Dolomite Enters Into Distribution Agreement With Sphere Fluidics For Picodroplet Applications 15
Sphere Fluidics Enters Into Co-Development Agreement With Dolomite Centre 16
Sphere Fluidics Secures License for Picodroplet Sorting 17
Sphere Fluidics Secures License for Surfactant Patent Family 18
Sphere Fluidics Enters Into Licensing Agreement with Cambridge University for Picodroplets 19
Sphere Fluidics Secures License for Picodroplet Technology 20
Sphere Fluidics Ltd, Key Competitors 21
Sphere Fluidics Ltd, Key Employees 22
Sphere Fluidics Ltd, Other Locations 23

★海外企業調査レポート[Sphere Fluidics Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dohler GmbH:企業の戦略・SWOT・財務分析
    Dohler GmbH - Strategy, SWOT and Corporate Finance Report Summary Dohler GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • China Pacific Insurance (Group) Co Ltd:戦略・SWOT・企業財務分析
    China Pacific Insurance (Group) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Pacific Insurance (Group) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Chemring Energetics UK Ltd:企業の戦略・SWOT・財務情報
    Chemring Energetics UK Ltd - Strategy, SWOT and Corporate Finance Report Summary Chemring Energetics UK Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Waterstone Financial Inc (WSBF):企業の財務・戦略的SWOT分析
    Waterstone Financial Inc (WSBF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Singapore Technologies Electronics Ltd:戦略・SWOT・企業財務分析
    Singapore Technologies Electronics Ltd - Strategy, SWOT and Corporate Finance Report Summary Singapore Technologies Electronics Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Global Payments Inc.:企業の戦略・SWOT・財務分析
    Global Payments Inc. - Strategy, SWOT and Corporate Finance Report Summary Global Payments Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Southwestern Energy Company:企業の戦略・SWOT・財務情報
    Southwestern Energy Company - Strategy, SWOT and Corporate Finance Report Summary Southwestern Energy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Immunicum AB (IMMU):企業の財務・戦略的SWOT分析
    Summary Immunicum AB (Immunicum) is a biopharmaceutical company that focuses on the development of immuno-oncology therapies for the treatment of solid tumors. The company’s lead development candidate, ilixadencel is in clinical trials for the treatment a range of solid tumors including hepatic cell …
  • Benesse Holdings Inc (9783):企業の財務・戦略的SWOT分析
    Benesse Holdings Inc (9783) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Carso Infraestructura y Construccion SA De CV:企業の戦略・SWOT・財務情報
    Carso Infraestructura y Construccion SA De CV - Strategy, SWOT and Corporate Finance Report Summary Carso Infraestructura y Construccion SA De CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Spicejet Limited
    Spicejet Limited - Strategy, SWOT and Corporate Finance Report Summary Spicejet Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • InspireMD Inc (NSPR):医療機器:M&Aディール及び事業提携情報
    Summary InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for us …
  • Itochu Enex Co Ltd (8133):企業の財務・戦略的SWOT分析
    Itochu Enex Co Ltd (8133) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Entersoft SA (ENTER):企業の財務・戦略的SWOT分析
    Entersoft SA (ENTER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Allergan Plc (AGN):企業の財務・戦略的SWOT分析
    Allergan Plc (AGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Pacira Pharmaceuticals Inc (PCRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Pacira Pharmaceuticals Inc (Pacira) discovers, develops, manufactures and commercializes drugs based on its proprietary DepoFoam drug delivery technology. Its lead product candidate, Exparel (bupivacaine liposome injectable suspension) is an amide-type local anesthetic indicated for infiltra …
  • Intersnack Group GmbH & Co. KG:企業の戦略・SWOT・財務情報
    Intersnack Group GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Intersnack Group GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Cytox Ltd-医療機器分野:企業M&A・提携分析
    Summary Cytox Ltd (Cytox) is a diagnostic and prognostic service provider that develops services for neurodegenerative disorders. The company’s blood tests are used to predict, which patients with MCI will develop Alzheimer's disease. Its biomarkers are based on the cell cycle hypothesis of Alzheime …
  • Systex Corp (6214):企業の財務・戦略的SWOT分析
    Systex Corp (6214) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Harmonic Inc (HLIT):企業の財務・戦略的SWOT分析
    Harmonic Inc (HLIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆